Sell 8/16/2024Downgrade
Tevogen Bio Holdings Inc. (TVGN) was downgraded to E+ from D on 8/16/2024 due to a significant decline in the efficiency index, growth index and total return index. Net income declined 185.78% from $11.26M to -$9.66M, earnings per share declined from $0.0765 to -$0.04, and total capital declined 50.83% from -$3.72M to -$5.62M.

Sell 6/7/2024Upgraded
Tevogen Bio Holdings Inc. (TVGN) was upgraded to D from E+ on 6/7/2024 due to a significant increase in the efficiency index and growth index. Net income increased 410.14% from -$3.63M to $11.26M, and earnings per share increased from -$0.1467 to $0.0765.

Sell 3/11/2024Downgrade
Tevogen Bio Holdings Inc. (TVGN) was downgraded to E+ from D- on 3/11/2024 due to a decline in the total return index and volatility index.

Sell 2/23/2024Upgraded
Tevogen Bio Holdings Inc. (TVGN) was upgraded to D- from E+ on 2/23/2024 due to a noticeable increase in the solvency index.

Sell 2/16/2024None
Tevogen Bio Holdings Inc. (TVGN) was downgraded to E+ from U on 02/16/2024.